NCT00017251: Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer |
|
|
| Completed | 1 | 12 | US | oblimersen sodium, augmerosen, G3139, G3139 bcl-2 antisense oligodeoxynucleotide, Genasense, carboplatin, Carboplat, CBDCA, JM-8, Paraplat, Paraplatin, etoposide, EPEG, VP-16, VP-16-213, pharmacological study, pharmacological studies, laboratory biomarker analysis | National Cancer Institute (NCI) | Extensive Stage Small Cell Lung Cancer | 01/04 | | | |
